Advanced search

819 Results

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Astrazeneca - Q1 2024 results	04-26	AQ
Transcript : AstraZeneca PLC, Q1 2024 Earnings Call, Apr 25, 2024	04-25
AstraZeneca: strong sales growth in Q1	04-25	CF
AstraZeneca upbeat as cancer drugs underpin sales growth	04-25	AN
Miner Anglo American reviews takeover bid from rival BHP	04-25	AN
Miner Anglo American eyes rival BHP takeover	04-25	AN
Q1 2024 results	04-25	BU
BRITAIN'S PROXY BATTLE REQUIRES A UNITED FRONT	04-18	AQ
Global markets live: BP, Apple, Vodafone, Ford, Lockheed Martin...	04-12
AstraZeneca Executives' Compensation Policy Passes With Low Shareholder Approval	04-11	DJ
AstraZeneca shareholders approve 2024 pay policy in boost to CEO Soriot	04-11	RE
AstraZeneca : Results of Annual General Meeting held on 11 April 2024	04-11	PU
AstraZeneca shareholders approve 2024 pay policy at AGM	04-11	RE
Europe takes hit on nerves ahead of ECB decision	04-11	AN
AstraZeneca announces dividend hike ahead of CEO pay vote	04-11	RE
PASCAL'S PROXY PAY PALAVER	04-10	AQ
ASTRAZENECA : AstraZeneca should not be overlooked for long	04-03
Global markets live: UBS, AT&T, Tesla, United Airlines, Humana, Wanda...	04-02
AstraZeneca CEO Soriot on Pharmaceuticals in China	03-27	MT
China to speed up 'new productive forces', vice president says	03-26	RE
German industry sceptical of China's vow to treat foreign firms equally	03-25	RE
AstraZeneca : 2023 Sustainability Highlights presentation	03-22	PU
AstraZeneca follows rival Boehringer in capping out-of-pocket costs for inhalers	03-18	RE
AstraZeneca caps patient out-of-pocket costs at $35 per month for its US inhaled respiratory portfolio	03-18	BU
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	03-12	PU
AstraZeneca : Proxy Form for 2024 AGM	03-07	PU
AstraZeneca Planning GBP650 Million Investment for U.K. Programs	03-06	DJ
AstraZeneca : Transaction by Person Discharging Managerial Responsibilities - Form 6-K	03-06	PU
AstraZeneca to invest 650 million pounds in UK to boost 'pandemic preparedness'	03-06	RE
GSK CEO Emma Walmsley's total pay rises 51% to nearly 13 million pounds in 2023	03-01	RE
ASTRAZENECA : UBS lowers target price	02-12	CF
AstraZeneca: further decline after two negative analyses	02-12	CF
Astrazeneca - Full Year and Q4 2023 results	02-09	AQ
AstraZeneca CEO Soriot: Entering the obesity market	02-08	MT
Transcript : AstraZeneca PLC, Q4 2023 Earnings Call, Feb 08, 2024	02-08
Astrazeneca says Catalent deal shows importance of in-house capacity	02-08	RE
AstraZeneca Shares Drop After Weak Quarterly Print Despite 2024 Growth Guidance -- 2nd Update	02-08	DJ
AstraZeneca: EPS up 5% in Q4	02-08	CF
Unilever up on buyback; BAT ups dividend	02-08	AN
AstraZeneca confident after 2023 profit more than doubles	02-08	AN
AstraZeneca Sees Double-Digit Growth for Core Earnings, Revenue in 2024 -- Update	02-08	DJ
Unilever sets new buyback; Astra profit surges	02-08	AN
AstraZeneca Sees Double-Digit Growth for Core Earnings, Revenue in 2024	02-08	DJ
AstraZeneca targets 2024 growth as portfolio booms	02-08	RE
AstraZeneca Full year and Q4 2023 Financial Results	02-08	BU
AstraZeneca launches Evinova, a health-tech business to accelerate innovation across the life sciences sector, the delivery of clinical trials and better health outcomes	11-20	BU
AstraZeneca launches new life sciences tech innovation firm Evinova	11-20	AN
AstraZeneca Launches Health-Tech Business Evinova -- Update	11-20	DJ
AstraZeneca Launches Health-Tech Business Evinova to Support Clinical Studies	11-20	DJ
AstraZeneca prioritizes US for RSV drug amid surge in cases	11-10	RE

No results for this search

Discover our Free Content to Help You Better Understand the Stock Market.

100% Free Registration

fermer